Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of California, San Francisco
About this trial
This is a prospective observational registry for patients with invasive lobular carcinoma (ILC) of the breast. After the first 1cohort is enrolled, the collected data will be utilized to develop an ILC specific response assessment tool.
Eligibility criteria
Qualifiers
Histologically confirmed invasive lobular carcinoma. Mixed lobular/ductal cancer is allowed.
Age >=18 years
Any receptor subtype.
Ability to understand a written informed consent document, and the willingness to sign it.
Disqualifiers
Stage I-III breast cancer.
Lack of lobular histology on tumor biopsy.
Other active cancer (prior treated cancer with no current evidence of disease is allowed).
Trial design
Treatments tested in this trial
- Blood Specimen
Treatment groups
12 Participants
are divided into 1 treatment groupLocations
4University of California, San Diego92053, San DiegoCalifornia, United States
University of California, San Francisco94122, San FranciscoCalifornia, United States
Abramson Cancer Center19104, PhiladelphiaPennsylvania, United States
MD Anderson Cancer Center77030, HoustonTexas, United States
Sponsors and collaborators
University of California, San Francisco
Lead sponsor
METAvivor Research and Support, Inc
Collaborator
Source ClinicalTrials.gov